| Albumin-based nanoparticles as potential controlled release drug delivery systems AO Elzoghby, WM Samy, NA Elgindy Journal of controlled release 157 (2), 168-182, 2012 | 1623 | 2012 |
| Protein-based nanocarriers as promising drug and gene delivery systems AO Elzoghby, WM Samy, NA Elgindy Journal of controlled release 161 (1), 38-49, 2012 | 894 | 2012 |
| Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research AO Elzoghby Journal of Controlled Release 172 (3), 1075-1091, 2013 | 717 | 2013 |
| Casein-based formulations as promising controlled release drug delivery systems AO Elzoghby, WSA El-Fotoh, NA Elgindy Journal of controlled release 153 (3), 206-216, 2011 | 532 | 2011 |
| Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates HM Abdelaziz, M Gaber, MM Abd-Elwakil, MT Mabrouk, MM Elgohary, ... Journal of Controlled Release 269, 374-392, 2018 | 325 | 2018 |
| Implications of protein-and peptide-based nanoparticles as potential vehicles for anticancer drugs AO Elzoghby, MM Elgohary, NM Kamel Advances in protein chemistry and structural biology 98, 169-221, 2015 | 188 | 2015 |
| Hybrid protein-inorganic nanoparticles: from tumor-targeted drug delivery to cancer imaging AO Elzoghby, AL Hemasa, MS Freag Journal of Controlled Release 243, 303-322, 2016 | 155 | 2016 |
| Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand AO Elzoghby, MA Abdelmoneem, IA Hassanin, MM Abd Elwakil, ... Biomaterials 263, 120355, 2020 | 141 | 2020 |
| Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer SA Sabra, AO Elzoghby, SA Sheweita, M Haroun, MW Helmy, ... European Journal of Pharmaceutics and Biopharmaceutics 128, 156-169, 2018 | 141 | 2018 |
| Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization, and in vivo pharmacokinetics AO Elzoghby, MW Helmy, WM Samy, NA Elgindy International journal of nanomedicine, 1721-1732, 2013 | 120 | 2013 |
| Novel spray-dried genipin-crosslinked casein nanoparticles for prolonged release of alfuzosin hydrochloride AO Elzoghby, WM Samy, NA Elgindy Pharmaceutical research 30, 512-522, 2013 | 111 | 2013 |
| Protein-lipid nanohybrids as emerging platforms for drug and gene delivery: challenges and outcomes M Gaber, W Medhat, M Hany, N Saher, JY Fang, A Elzoghby Journal of Controlled Release 254, 75-91, 2017 | 106 | 2017 |
| Natural polymeric nanoparticles for brain-targeting: implications on drug and gene delivery A O Elzoghby, M M Abd-Elwakil, K Abd-Elsalam, M T Elsayed, Y Hashem, ... Current pharmaceutical design 22 (22), 3305-3323, 2016 | 103 | 2016 |
| Spray-dried casein-based micelles as a vehicle for solubilization and controlled delivery of flutamide: Formulation, characterization, and in vivo pharmacokinetics AO Elzoghby, MW Helmy, WM Samy, NA Elgindy European Journal of Pharmaceutics and Biopharmaceutics 84 (3), 487-496, 2013 | 97 | 2013 |
| Albumin-based nanoparticles: A promising strategy to overcome cancer drug resistance I Hassanin, A Elzoghby Cancer drug resistance 3 (4), 930, 2020 | 96 | 2020 |
| Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy OM Ali, AA Bekhit, SN Khattab, MW Helmy, YS Abdel-Ghany, M Teleb, ... Colloids and Surfaces B: Biointerfaces 188, 110824, 2020 | 94 | 2020 |
| Shell-crosslinked zein nanocapsules for oral codelivery of exemestane and resveratrol in breast cancer therapy AO Elzoghby, SA El-Lakany, MW Helmy, MM Abu-Serie, NA Elgindy Nanomedicine 12 (24), 2785-2805, 2017 | 85 | 2017 |
| Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma DM Kabary, MW Helmy, KA Elkhodairy, JY Fang, AO Elzoghby Colloids and Surfaces B: Biointerfaces 169, 183-194, 2018 | 78 | 2018 |
| Inhalable lactoferrin–chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma MM Abd Elwakil, MT Mabrouk, MW Helmy, EZA Abdelfattah, SK Khiste, ... Nanomedicine 13 (16), 2015-2035, 2018 | 78 | 2018 |
| Zein-based nanocarriers as potential natural alternatives for drug and gene delivery: focus on cancer therapy A Elzoghby, M Freag, H Mamdouh, K Elkhodairy Current pharmaceutical design 23 (35), 5261-5271, 2017 | 77 | 2017 |
Maged Wasfy HelmyFaculty of Pharmacy, Damanhour University, Egypt.在 pharm.dmu.edu.eg 的电子邮件经过验证
